The company will sell 7.15 million common shares at its initial public offering (IPO) at between $13 and $15 each, according to Gevo's regulatory filing.
Gevo, an US-based developer of biofuels backed by French oil major Total’s corporate venturing unit, plans to raise $123m at its Nasdaq flotation with an initial market capitalisation of $373m at the top end of its range.
The company will sell 7.15 million common shares at its initial public offering (IPO) at between $13 and $15 each, according to Gevo’s regulatory filing. Investment banks UBS, Piper Jaffray and Citigroup can also sell a further 1.1 million shares if there…
